Results 261 to 270 of about 1,510,443 (341)
Explaining the Slow Adoption of AI Innovations in Health Care: Network Analysis Approach. [PDF]
Apell P, Locher S, Milde A, Eriksson H.
europepmc +1 more source
This study analyzes gut bacteria in cholangiocarcinoma patients, revealing distinct microbial signatures that enable accurate disease detection. Species‐based diagnostic models achieved over 98% accuracy in identifying cholangiocarcinoma and distinguished it from other liver diseases. The research demonstrates that specific beneficial bacteria suppress
Benchen Rao +18 more
wiley +1 more source
A latent class analysis of cardiometabolic risk factors and the predicted prevalence of subclinical atherosclerosis in middle-aged Swedish adults. [PDF]
Anindya K +7 more
europepmc +1 more source
Emerging evidence suggests that intraneuronal Aβ accumulation represents an early pathogenic event in Alzheimer's disease (AD). Using Drosophila AD model, this study shows that a nonsecreted serine protease Yip7 physically interacts with Aβ. This causes intraneuronal Aβ accumulation but surprisingly reduces the associated neurotoxicity, arguing that ...
Jingyun Su +4 more
wiley +1 more source
No Loan Comes Without a Price: Financial Literacy, Mental Health, and Consumer Loan Use Among Young Adults in Sweden. [PDF]
Levinsson H +3 more
europepmc +1 more source
PirN was identified as a previously uncharacterized PsbO‐interacting protein specifically induced in nitrate‐grown cyanobacteria. Loss of PirN leads to coordinated downregulation of PsbO and the nitrate reductase NarB, causing decreased PSII activity and impaired growth under nitrate conditions. Complementation with either PsbO or NarB largely restores
Chengcheng Huang +16 more
wiley +1 more source
Reply: On Gender-Specific FIT Cutoffs in the Swedish Colorectal Cancer Screening Program. [PDF]
Hreinsson JP, Pålsson B, Blom J.
europepmc +1 more source
Cognitive Trajectories from Preclinical Alzheimer's Disease to Dementia
A continuous, multi‐domain characterization of cognitive decline across the Alzheimer's disease spectrum identifies when individual cognitive measures become abnormal. Episodic memory declines first, followed by executive function, language, processing speed, and visuospatial abilities, supporting improved clinical interpretation and optimized endpoint
Fredrik Öhman +3 more
wiley +1 more source

